NeuroBionics is pioneering the future of precision bioelectronic medicine by developing the next generation of implantable devices, designed to seamlessly interface with the human body. Our core technology lies in flexible, multifunctional fibers the size of a human hair, which can record and stimulate neural activity, deliver drugs, and ablate tissue. Using an endovascular approach, we will navigate our microscopic-sized flexible fiber implant through the intricate network of blood vessels to deliver precise therapeutic intervention to neural tissue. By making neural interfacing a minimally-invasive procedure, we will revolutionize deep brain stimulation and broaden access to this lifechanging therapy. By doing so, we aim to improve the lives of millions grappling with conditions like Parkinson's disease, essential tremor, epilepsy, and depression.
Company Details
- Employees
- 11
- Founded
- -
- Address
- 444 Somerville Ave, Somerville,massachusetts 02143,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://neurobionics.io/
- HQ
- Somerville, Massachusetts
Neurobionics Questions
Neurobionics's website is https://neurobionics.io/
Neurobionics's LinkedIn profile is https://www.linkedin.com/company/neurobionics
Neurobionics has
11 employees.
View email and phone details for 11
employees at Neurobionics.
Neurobionics's industry is
Biotechnology Research
Neurobionics's top competitors are
Akeyna,
Accurkardia,
Ice Neurosystems, Inc.,
Samay,
Brainspace,
Vonova,
Sanaheal, Inc.,
Flow Medical,
Medtech Innovator,
Juniper Biomedical.
Neurobionics's categories are Biotechnology Research
Neurobionics's founding year is 2023
